CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.
CMS Expands Medicare Drug Price Talks To Part B Meds In 2026 Shake Up
Where Today's News Shapes Tomorrow